This House resolution recognizes Charcot-Marie-Tooth disease (CMT) and calls for robust research funding through the National Institute of Neurological Disorders and Stroke at the National Institutes of Health. It says CMT damages peripheral nerves, is usually inherited, and affects an estimated 126,000 people in the United States. The resolution also notes that federal funding for CMT research was lower in 2022 than in 2021. It expresses support for continued research on CMT and other rare diseases without a cure.
The resolution expresses support for CMT research. It does not provide direct services or change benefits for people with CMT.
The resolution does not specify expenses. No publicly available information.
The resolution states that CMT affects thousands of Americans and millions of people worldwide, and that research funding should be robust to study the disease and other rare diseases without a cure.
No publicly available information.